Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...
MONTREAL, Dec. 2, 2025 /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited ...
Taylor Prater, our Faces off the field interview, enjoys Georgetown basketball's culture of excellence. This year's team ...
KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...
ANSWER Scholarship empowers mothers like Amber House with financial aid and mentorship, enabling them to complete degrees and inspire their families ...
PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first ...
The Federal Reserve is widely expected to trim interest rates on Wednesday, but if Chair Jerome Powell wants to give markets ...
Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...
Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...
Boeing has awarded $85,000 to ReMerge's FutureBound Workforce Readiness Initiative, which offers work certifications for high ...
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood ...